OPNT - Opiant Pharmaceuticals Inc. (OPNT) CEO Roger Crystal on Q1 2021 Results - Earnings Call Transcript

Opiant Pharmaceuticals, Inc. (OPNT) Q1 2021 Results Conference Call May 11, 2021 04:30 PM ET Company Participants Ben Atkins - Vice President of Communications and Investor Relations Roger Crystal - Chief Executive Officer David O'Toole - Chief Financial Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Carl Byrnes - Northland Capital David Bautz - Zacks Small Cap Research Presentation Operator Greetings. Welcome to the Opiant Pharmaceuticals’ First Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to your host, Ben Atkins. You may begin. Ben Atkins Thank you, operator, and thank you all for joining us this afternoon. With me on today's call, our Chief Executive Officer, Dr. Roger Crystal; and Chief Financial Officer, David O'Toole. This afternoon,

For further details see:

Opiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q1 2021 Results - Earnings Call Transcript